A case–control study based on a population-based serum bank established in Washington County, Maryland, which included 118 CRC patients and 118 controls, showed that TP was significantly lower in CRC patients than in controls.[14] To our knowledge, there is a lack of studies on the causal relationship between ALB, TP, and CRC in European populations. The gene discussed is ALB; the disease is colorectal carcinoma.